Leading in physical manufacturing and filing for an IPO, though facing potential US regulatory risks.

Experiencing 335% YoY revenue growth, though faces significant geopolitical risk from US legislative restrictions.

Identified as a significant competitor in the humanoid robot space with supply chain advantages in China.

Global leader in humanoid robot shipments with doubling profits and successful price compression for mass deployment.

Developing advanced humanoid robots with high agility, contributing to a mass-production trend for 2026.

The upcoming IPO is highlighted as an 'interesting pure-play opportunity' within the 'nascent but rapidly accelerating investment theme' of robotics.

An IPO is expected this year, which will offer public investors a way to gain exposure to the advanced humanoid robotics theme as the sector moves from 'demos to deployment' with superhuman capabilities.

Projected to IPO next year at a $20-50B valuation, representing a potential entry point into the humanoid robot market, which is seen as significantly underappreciated.

Their robot finished first in a 100-meter race but was remote-controlled, signaling that the market values autonomy over raw physical capability, which was viewed as a less advanced approach.